Correlation Between Genetic Technologies and Hansen Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genetic Technologies and Hansen Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genetic Technologies and Hansen Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genetic Technologies and Hansen Technologies, you can compare the effects of market volatilities on Genetic Technologies and Hansen Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genetic Technologies with a short position of Hansen Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genetic Technologies and Hansen Technologies.

Diversification Opportunities for Genetic Technologies and Hansen Technologies

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Genetic and Hansen is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Genetic Technologies and Hansen Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hansen Technologies and Genetic Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genetic Technologies are associated (or correlated) with Hansen Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hansen Technologies has no effect on the direction of Genetic Technologies i.e., Genetic Technologies and Hansen Technologies go up and down completely randomly.

Pair Corralation between Genetic Technologies and Hansen Technologies

Assuming the 90 days trading horizon Genetic Technologies is expected to under-perform the Hansen Technologies. In addition to that, Genetic Technologies is 1.04 times more volatile than Hansen Technologies. It trades about -0.01 of its total potential returns per unit of risk. Hansen Technologies is currently generating about 0.13 per unit of volatility. If you would invest  463.00  in Hansen Technologies on September 25, 2024 and sell it today you would earn a total of  71.00  from holding Hansen Technologies or generate 15.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Genetic Technologies  vs.  Hansen Technologies

 Performance 
       Timeline  
Genetic Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genetic Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Genetic Technologies is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Hansen Technologies 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Hansen Technologies are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Hansen Technologies unveiled solid returns over the last few months and may actually be approaching a breakup point.

Genetic Technologies and Hansen Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genetic Technologies and Hansen Technologies

The main advantage of trading using opposite Genetic Technologies and Hansen Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genetic Technologies position performs unexpectedly, Hansen Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hansen Technologies will offset losses from the drop in Hansen Technologies' long position.
The idea behind Genetic Technologies and Hansen Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance